The Effects of HIV Protease Inhibitors in Severe Sepsis
NCT00346580
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Nelfinavir
Sponsor
Mayo Clinic